-
EP4211153
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4211153
| EP4211153 - ENGINEERED HUMAN FVIII WITH ENHANCED SECRETION ABILITY AND CLOTTING ACTIVITY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 01.03.2024 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 16.06.2023 | ||
| Former | The international publication has been made Status updated on 02.06.2023 | ||
| Former | unknown Status updated on 09.06.2022 | Most recent event Tooltip | 18.10.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states SICHUAN REAL&BEST BIOTECH CO., LTD. 10/F, Building D2, No. 18, Section 2 Shuangliu Biocity Road (M) Chengdu Tianfu International Bio-Town Chengdu, Sichuan 610219 / CN | [2023/29] | Inventor(s) | 01 /
DONG, Biao Chengdu, Sichuan 610219 / CN | 02 /
ZHANG, Bo Chengdu, Sichuan 610219 / CN | 03 /
YE, Jingya Chengdu, Sichuan 610219 / CN | 04 /
XIAO, Lin Chengdu, Sichuan 610219 / CN | 05 /
ZHENG, Zhaoyue Chengdu, Sichuan 610219 / CN | 06 /
YANG, Li Chengdu, Sichuan 610219 / CN | 07 /
LIU, Yu Chengdu, Sichuan 610219 / CN | [2023/29] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
| Former [2023/29] | FRKelly 27 Clyde Road Dublin D04 F838 / IE | Application number, filing date | 22726380.3 | 11.02.2022 | [2023/29] | WO2022CN75976 | Priority number, date | WO2021CN133004 | 25.11.2021 Original published format: PCT/CN2021/133004 | [2023/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023092864 | Date: | 01.06.2023 | Language: | EN | [2023/22] | Type: | A1 Application with search report | No.: | EP4211153 | Date: | 19.07.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.06.2023 takes the place of the publication of the European patent application. | [2023/29] | Search report(s) | International search report - published on: | CN | 01.06.2023 | (Supplementary) European search report - dispatched on: | EP | 02.10.2023 | Classification | IPC: | C07K14/755, C12N15/12, A61K38/37, C12N5/10, A61K48/00, C12N15/86 | [2023/44] | CPC: |
C07K14/755 (EP,US);
C12N15/86 (EP,US);
A61K38/00 (US);
A61K48/005 (EP);
C07K2319/00 (EP);
C12N2750/14143 (EP,US)
|
| Former IPC [2023/29] | C07K14/755, C12N15/12, A61K38/37, C12N5/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/29] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | MANIPULIERTES MENSCHLICHES FVII1 MIT ERHÖHTER SEKRETIONSFÄHIGKEIT UND GERINNUNGSAKTIVITÄT | [2023/29] | English: | ENGINEERED HUMAN FVIII WITH ENHANCED SECRETION ABILITY AND CLOTTING ACTIVITY | [2023/29] | French: | FACTEUR VIII HUMAIN MODIFIÉ AYANT UNE CAPACITÉ DE SÉCRÉTION ET UNE ACTIVITÉ DE COAGULATION AMÉLIORÉES | [2023/29] | Entry into regional phase | 08.06.2022 | National basic fee paid | 08.06.2022 | Search fee paid | 08.06.2022 | Designation fee(s) paid | 08.06.2022 | Examination fee paid | Examination procedure | 08.06.2022 | Examination requested [2023/29] | 09.11.2023 | Amendment by applicant (claims and/or description) | 09.11.2023 | Date on which the examining division has become responsible | 29.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 07.06.2024 | Reply to a communication from the examining division | 16.07.2024 | Despatch of a communication from the examining division (Time limit: M04) | 30.08.2024 | Reply to a communication from the examining division | 17.10.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 19.02.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2014209942 (XIAO WEIDONG [US]); | [X]WO2016123200 (UNIV EMORY [US], et al); | International search | [A]EP1502921 (ZLB BEHRING GMBH [DE]); | [A]WO2008129422 (LFB BIOTECHNOLOGIES [FR], et al); | [A]WO2013123457 (BIOGEN IDEC INC [US]); | [A]WO2015023894 (BIOGEN IDEC INC [US]); | [A]WO2017222330 (MOGAM INST BIOMEDICAL RES [KR]) |